Lentiviral vector-encoded microRNA-based shRNA-mediated gene knockdown of N-methyl-D-aspartate receptors in skin reduces pain

详细信息    查看全文

• 作者：Chien-Cheng Liu ; Jiin-Tsuey Cheng ; Kuo-Chuan Hung ; Yuan-Yi Chia and Ping-Heng Tan
• 刊名：Brain and Behavior
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：7
• 期：1
• 全文大小：867K
• ISSN：2157-9032

文摘

RNA polymerase II promoters that drive the expression of rationally designed primary microRNA-based shRNA, for example, shRNAmir, can produce more potent gene knockdown than RNA polymerase III promoters. Antagonists of peripheral N methyl-D-aspartate (NMDA) receptors that do not interfere with central glutamate processing would prevent the development of adverse central nervous system effects. Thus, in this study, we examined the effects of gene silencing and antinociception on formalin- and Complete Freund's adjuvant (CFA)-induced pain in rats by subcutaneously injecting a lentiviral vector encoding a shRNAmir that targets the NR1 subunit of the NMDA receptor.